Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep

NCT03575104 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

924

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: Daridorexant
OTHER: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.